SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalculus Vct Regulatory News (CLC)

Share Price Information for Calculus Vct (CLC)

Share Price is delayed by 15 minutes
Get Live Data
53.25    0.00 (0.00%)
Bid:
48.00
Ask:
58.50
Spread: 10.50 (21.875%)
Market Cap: £51.93m
CLC Live PriceLast checked at - London Stock Exchange

Intraday Calculus Vct Share Chart

Annual Information Update

26 Jun 2012 17:07

INVESTEC STRUCTURED PRODUCTS CALCULUS VCT PLC

Annual Information Update

In accordance with Prospectus Rule 5.2 the Company reports upon information that it has published or made available to the public over the twelve month period ended 25 June 2012.

In accordance with Prospectus Rule 5.2.7, it is acknowledged that whilst the information referred to below was correct at the time of publication, such disclosures may, at any time, become out of date due to changing circumstances.

Company Announcements

The Company has made the following announcements through PR Newswire, it'sappointed RIS.Date Announcement 30/06/2011 Result of AGM 04/07/2011 Interim Management Statement 11/07/2011 Circular re Related Party Transaction 12/07/2011 Results of Separate Class Meetings 22/07/2011 Net Asset Value 05/08/2011 Result of EGM 19/08/2011 Net Asset Value 16/09/2011 Net Asset Value 17/10/2011 Net Asset Value 31/10/2011 Half-yearly Report 22/11/2011 Net Asset Value 20/12/2011 Net Asset Value 17/01/2012 Interim Management Statement 16/02/2012 Net Asset Value 15/03/2012 Net Asset Value 24/04/2012 Net Asset Value 16/05/2012 Net Asset Value 01/06/2012 Annual Financial Report

Copies of all regulatory announcements may be viewed on the London Stock Exchange website at www.londonstockexchange.com. Please note that this site is not the responsibility of the Company.

Filing at Companies House

During the period the following documents were filed at Companies House:

Date available Document number Description on Companies House website 07/07/2011 AA Full Accounts made up to 28/02/2011 12/07/2011 TM01 Director appointment terminated, Director Ian Wohlman 26/07/2011 RES10 Resolutions passed at AGM 27/07/2011 RES13 Resolutions passed at Separate Class Meetings 23/11/2011 CERT21 Reduction of share premium 23/11/2011 OC138 Reduction of ISS capital and minute (OC) 23/11/2011 SH19 Statement of capital 23/02/2012 CH01 Director's change of particulars/ Michael O'Higgins AR01 Annual Return

Copies of documents filed at Companies House are available from the Registrar of Companies, Companies House, Crown Way, CARDIFF, CF14 3UZ, telephone 0870 33 33 636, email enquiries@companies-house.gov.uk, or for registered users through Companies House Direct, www.direct.companieshouse.gov.uk.

Documents published and sent to shareholders

The following documents have been published by the Company and sent toshareholders of the Company:Date of Publication Document 11/07/2011 Circular re Related Party Transactions 31/10/2011 Half-yearly Report 01/06/2012 Annual Report and Accounts Inspection of DocumentsThe documents below are also available on the Calculus Capital Limited website:www.calculuscapital.comAnnual Report and AccountsHalf Yearly ReportsInterim Management StatementsMonthly Net asset Values

Copies of certain documents that were required to be lodged at the FSA in accordance with the Listing Rules, Prospectus Rules and Disclosure Rules can be viewed at: www.hemscott.com/nsm.do

Copies of any of the above items may be obtained free of charge from the office of the Company Secretary at the registered office address:

Capita Sinclair Henderson Limited51 New North RoadExeterEX4 4EP26 June 2012

XLON
Date   Source Headline
22nd Apr 20263:39 pmRNSTransaction in Own Shares
31st Mar 20265:55 pmRNSDirectorate change
25th Mar 20262:23 pmRNSIssue of Equity
18th Feb 20263:14 pmRNSIssue of Equity
22nd Jan 20269:29 amRNSTransaction in Own Shares
16th Jan 20264:34 pmRNSNet Asset Value(s)
14th Jan 20263:00 pmRNSDividend Declaration
18th Dec 20252:30 pmRNSIssue of Equity
18th Dec 20252:30 pmRNSIssue of Equity
17th Dec 20253:15 pmRNSIssue of Equity
15th Dec 20253:10 pmRNSHalf-year Financial Report
14th Oct 20254:33 pmRNSTransaction in Own Shares
3rd Oct 202511:42 amRNSPublication of a Prospectus
2nd Oct 20254:29 pmRNSIssue of Equity
24th Sep 202511:22 amRNSResult of AGM & Change in Directorship
2nd Sep 20252:48 pmRNSIssue of Equity
28th Aug 202512:38 pmRNSPublication of Supplementary Prospectus
27th Aug 20252:52 pmRNSNet Asset Value
31st Jul 20259:46 amRNSAnnual Report with updated dividend details
30th Jul 202511:31 amRNSAnnual Financial Report &Related Party Transaction
3rd Jul 20259:17 amRNSIssue of Equity
10th Jun 20254:41 pmRNSTransaction in Own Shares
5th Jun 20254:39 pmRNSTransaction in Own Shares
4th Apr 20255:15 pmRNSIssue of Equity
26th Mar 20253:21 pmRNSIssue of Equity
11th Mar 20255:11 pmRNSChange of auditor
20th Feb 20254:30 pmRNSIssue of Equity
12th Feb 20254:39 pmRNSTransaction in Own Shares
21st Jan 20255:11 pmRNSNet Asset Value(s)
10th Jan 20253:46 pmRNSIssue of Equity update
18th Dec 20244:24 pmRNSIssue of Equity - 18 December 2024
5th Dec 20245:25 pmRNSHalf-year Report
14th Oct 20241:40 pmRNSPublication of a Prospectus
8th Oct 20245:23 pmRNSTransaction in Own Shares
9th Sep 202411:48 amRNSStatement re Intention to Fund Raise
29th Aug 20245:32 pmRNSIssue of Equity
22nd Aug 20244:27 pmRNSResults of Annual General Meeting
31st Jul 20245:44 pmRNSIssue of Equity
17th Jul 20241:51 pmRNSNet Asset Value(s)
11th Jul 20245:38 pmRNSAnnual Financial Report
24th Apr 20244:49 pmRNSTransaction in Own Shares
5th Apr 20242:54 pmRNSIssue of Equity - 5 April 2024
22nd Feb 20244:38 pmRNSDirectorship Change
15th Feb 202411:53 amRNSIssue of Equity - 15 February 2024
1st Feb 20244:38 pmRNSNet Asset Value - 31 December 2023
10th Jan 20245:27 pmRNSTransaction in Own Shares
21st Dec 202310:08 amRNSDirectorate Change
15th Dec 20233:25 pmRNSIssue of Equity - 15 December 2023
20th Nov 20232:11 pmRNSSeptember 2023 NAV Announcement
13th Nov 20234:46 pmRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.